These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30416485)

  • 41. Real-time monitoring of focused ultrasound blood-brain barrier opening via subharmonic acoustic emission detection: implementation of confocal dual-frequency piezoelectric transducers.
    Tsai CH; Zhang JW; Liao YY; Liu HL
    Phys Med Biol; 2016 Apr; 61(7):2926-46. PubMed ID: 26988240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
    Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
    Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
    Barth RF; Yang W; Bartus RT; Rotaru JH; Ferketich AK; Moeschberger ML; Nawrocky MM; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):858-68. PubMed ID: 11849812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.
    Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
    Brain Res; 2001 May; 900(2):157-62. PubMed ID: 11334793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focused ultrasound-mediated drug delivery through the blood-brain barrier.
    Burgess A; Shah K; Hough O; Hynynen K
    Expert Rev Neurother; 2015 May; 15(5):477-91. PubMed ID: 25936845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M; McDannold N; Jolesz FA; Hynynen K
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1085-90. PubMed ID: 16403441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
    Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
    PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC; Egleton RD; Davis TP
    Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
    Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
    Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening.
    Sun T; Samiotaki G; Wang S; Acosta C; Chen CC; Konofagou EE
    Phys Med Biol; 2015 Dec; 60(23):9079-94. PubMed ID: 26562661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Observations on exsudation of fibronectin, fibrinogen and albumin in the brain after carotid infusion of hyperosmolar solutions. An immunohistochemical study in the rat indicating longlasting changes in the brain microenvironment and multifocal nerve cell injuries.
    Salahuddin TS; Kalimo H; Johansson BB; Olsson Y
    Acta Neuropathol; 1988; 76(1):1-10. PubMed ID: 3293343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening.
    Jones RM; Deng L; Leung K; McMahon D; O'Reilly MA; Hynynen K
    Theranostics; 2018; 8(11):2909-2926. PubMed ID: 29896293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Chi OZ; Chang Q; Wang G; Weiss HR
    Anesth Analg; 1997 Feb; 84(2):370-5. PubMed ID: 9024031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of early blood-brain barrier disruption by in situ brain perfusion technique.
    Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
    Brain Res Brain Res Protoc; 2001 Oct; 8(2):126-31. PubMed ID: 11673094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood-brain barrier disruption in immature Fischer 344 rats.
    Bullard DE; Bigner DD
    J Neurosurg; 1984 Apr; 60(4):743-50. PubMed ID: 6423781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats.
    Rousseau V; Denizot B; Pouliquen D; Jallet P; Le Jeune JJ
    MAGMA; 1997 Sep; 5(3):213-22. PubMed ID: 9351025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
    Hasarmeh M; Itzik A; Weidenfeld J; Ovadia H
    Neuroimmunomodulation; 2016; 23(1):1-7. PubMed ID: 26670748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.